Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ketamine for prevention of fentanyl-induced cough in children
IRCT20160307026950N88Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine in cough (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Incidence of fentanyl-induced cough, Severity of fentanyl-induced cough and 8 more. Started Sep 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20160307026950N88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N88.